These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 3671460

  • 21. Pharmacokinetics of phenazone (antipyrine) in rabbits with experimental common bile duct obstruction.
    Wójcicki J, Sulikowski T, Wójcicki M, Droździk M, Gawrońska-Szklarz B, Barcew-Wiszniewska B, Skowron J, Rózewicka L.
    Br J Pharmacol; 1996 Jan; 117(1):1-4. PubMed ID: 8825335
    [Abstract] [Full Text] [Related]

  • 22. Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat.
    Fenyves D, Gariépy L, Villeneuve JP.
    Hepatology; 1993 Feb; 17(2):301-6. PubMed ID: 8428728
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs.
    Siebert GA, Hung DY, Chang P, Roberts MS.
    J Pharmacol Exp Ther; 2004 Jan; 308(1):228-35. PubMed ID: 14566005
    [Abstract] [Full Text] [Related]

  • 25. The effect of cimetidine on the pharmacokinetics of salicylic acid.
    Trnavská Z, Trnavský K, Smondrk J.
    Drugs Exp Clin Res; 1985 Jan; 11(10):703-7. PubMed ID: 3836857
    [Abstract] [Full Text] [Related]

  • 26. Effects of propranolol and hemodialysis on the response of glucose, insulin, C-peptide and cyclic AMP to glucagon challenge.
    Pun KK, Yeung CK, Ho PW, Lin HJ, Chan MK, Yeung RT.
    Clin Nephrol; 1984 Apr; 21(4):235-40. PubMed ID: 6329569
    [Abstract] [Full Text] [Related]

  • 27. Effect of interstitial cystitis on drug absorption from urinary bladder.
    Gao X, Buffington CA, Au JL.
    J Pharmacol Exp Ther; 1994 Nov; 271(2):818-23. PubMed ID: 7965801
    [Abstract] [Full Text] [Related]

  • 28. Interaction of pargyline with tolbutamide in rabbits.
    Satyanarayana S, Krishna DM, Krishnaiah YS, Visweswaram D.
    Indian J Physiol Pharmacol; 1995 Jan; 39(1):71-3. PubMed ID: 7705875
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Propranolol disposition in the single-pass isolated, perfused rat liver in the presence and absence of insulin and glucagon.
    Semple HA, Xia F.
    Drug Metab Dispos; 1994 Jan; 22(6):822-6. PubMed ID: 7895597
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis.
    Braillon A, Calès P, Lebrec D.
    Int J Clin Pharmacol Res; 1985 Jan; 5(4):223-8. PubMed ID: 4055165
    [Abstract] [Full Text] [Related]

  • 34. Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat.
    Belpaire FM, de Smet F, Chindavijak B, Fraeyman N, Bogaert MG.
    Fundam Clin Pharmacol; 1989 Jan; 3(2):79-88. PubMed ID: 2722116
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Pharmacokinetics of propranolol, phenytoin and lidocaine in hypercholesterolemic rabbits].
    Vinçon G, Ploux D, Pehourcq F, Albin H.
    J Pharmacol; 1983 Jan; 14(1):47-55. PubMed ID: 6834851
    [Abstract] [Full Text] [Related]

  • 37. Drug interactions with spiramycin: lack of influence on antipyrine pharmacokinetics.
    Descotes J, Evreux JC.
    Chemioterapia; 1987 Jun; 6(2 Suppl):337-8. PubMed ID: 3509440
    [No Abstract] [Full Text] [Related]

  • 38. Effect of fusidic acid on the hepatic cytochrome P450 enzyme system.
    Reimann G, Barthel B, Rockstroh JK, Spatz D, Brockmeyer NH.
    Int J Clin Pharmacol Ther; 1999 Nov; 37(11):562-6. PubMed ID: 10584978
    [Abstract] [Full Text] [Related]

  • 39. Monthly variations in the pharmacokinetics of antipyrine in calves.
    Janus K, Baranow-Baranowski S, Jakubowska D, Jankowiak D, Skrzypczak WF.
    Arch Vet Pol; 1992 Nov; 32(3-4):113-8. PubMed ID: 1339566
    [Abstract] [Full Text] [Related]

  • 40. Antipyrine pharmacokinetics in the tail-suspended rat model.
    Brunner LJ, DiPiro JT, Feldman S.
    J Pharmacol Exp Ther; 1995 Jul; 274(1):345-52. PubMed ID: 7616419
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.